Home  »  News   »  Defying the odds and beating analyst forecasts: Am...

Defying the odds and beating analyst forecasts: Amgen Inc. (AMGN)

For the readers interested in the stock health of Amgen Inc. (AMGN). It is currently valued at $234.57. When the transactions were called off in the previous session, Stock hit the highs of $234.66, after setting-off with the price of $233.74. Company’s stock value dipped to $230.06 during the trading on the day. When the trading was stopped its value was $234.90.Recently in News on March 9, 2023, AMGEN TO PRESENT AT THE 33rd ANNUAL OPPENHEIMER HEALTHCARE CONFERENCE. Amgen (NASDAQ:AMGN) will present at the 2023 Oppenheimer Healthcare Conference at 2:00 p.m. ET on Monday, March 13, 2023. Susan Sweeney, senior vice president, Global Marketing, Access and Capabilities at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public. You can read further details here

Amgen Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $296.67 on 11/08/22, with the lowest value was $223.30 for the same time period, recorded on 09/22/22.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


Amgen Inc. (AMGN) full year performance was 1.30%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Amgen Inc. shares are logging -20.93% during the 52-week period from high price, and 5.05% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $223.30 and $296.67.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2320290 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Amgen Inc. (AMGN) recorded performance in the market was -10.69%, having the revenues showcasing -13.84% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 124.11B, as it employees total of 25200 workers.

Analysts verdict on Amgen Inc. (AMGN)

During the last month, 7 analysts gave the Amgen Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 15 analysts were recommending to HOLD this stock, 2 of them gave the stock UNDERWEIGHT rating, and 2 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 261.24, with a change in the price was noted -12.88. In a similar fashion, Amgen Inc. posted a movement of -5.21% for the period of last 100 days, recording 2,667,753 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for AMGN is recording 10.64 at the time of this writing. In addition, long term Debt to Equity ratio is set at 10.20.

Amgen Inc. (AMGN): Technical Analysis

Raw Stochastic average of Amgen Inc. in the period of last 50 days is set at 17.83%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 55.51%. In the last 20 days, the company’s Stochastic %K was 47.48% and its Stochastic %D was recorded 39.60%.

Let’s take a glance in the erstwhile performances of Amgen Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -10.69%. Additionally, trading for the stock in the period of the last six months notably improved by 2.83%, alongside a boost of 1.30% for the period of the last 12 months. The shares increased approximately by 3.89% in the 7-day charts and went up by -2.68% in the period of the last 30 days. Common stock shares were lifted by -13.84% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts